Focus Universal Trading Resumes

Written by Emily J. Thompson, Senior Investment Analyst

Updated: Feb 09 2026

0mins

FCUV+14.68%

Should l Buy FCUV?

Focus Universal trading resumes

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy FCUV?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on FCUV

About FCUV

Focus Universal Inc. is a provider of patented hardware and software design technologies for the Internet of Things (IoT) and fifth generation (5G). The Company has developed five disruptive patented technology platforms to solve the major problems facing hardware and software design and production within the industry. Perfecular, AVX, doing business as Smart AVX and Lusher jointly operate the SEC Financial Software segment, which involves the development, marketing, and production of its SEC Financial Reporting AI-Driven Automation Software package and also includes its universal smart instruments and devices in the hydroponic and controlled agriculture segments. AVX and Smart AVX (inclusive of the smart IoT Products sales under Smart AVX) run its LED and IoT Installation Services segment, which handles its IoT installation and management business, specializing in high performance and easy to use audio/video systems, home theaters, lighting control, automation, and integration.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split, Shares Plunge 38.4%

Dec 26 2025Benzinga

Reverse Stock Split Announcement: Aptevo Therapeutics has announced a 1-for-18 reverse stock split effective December 29, converting every 18 shares into one, which has led to a significant 38.4% drop in share price to $0.57, indicating a negative market reaction despite prior shareholder approval in July.
Severe Market Reaction: Following the reverse stock split announcement, Aptevo's shares plummeted sharply during Friday's session, reflecting investor concerns about the company's future prospects, which could adversely affect its financing capabilities and market confidence.
Shareholder Approval Context: The final ratio for the reverse split was approved by the board in mid-December, despite having received shareholder support at the July annual meeting, yet the market's response raises questions about the company's governance and strategic direction.
Industry Impact: The sharp decline in Aptevo's stock price may affect its competitive position in the biopharmaceutical sector, particularly regarding financing and partnership opportunities, as investors may reassess its investment value.

Spartan Capital Securities, LLC Acts as Lead Placement Agent for Focus Universal Inc.'s $10 Million Preferred Equity Raise

Oct 27 2025Globenewswire

Investment Announcement: Spartan Capital Securities, LLC has successfully closed a $10 million preferred equity offering for Focus Universal Inc. to support its Universal Smart IoT platform and AI-driven SEC financial reporting software.
Funding Details: The offering, completed on October 23, 2025, included a $7 million round led by Spartan Capital, providing Focus with essential resources for commercialization.
Company Statements: John Lowry, CEO of Spartan Capital, expressed pride in supporting Focus Universal's innovative advancements in IoT and AI technologies.
Legal and Compliance Notes: The securities sold in this private placement were not registered under the Securities Act of 1933 and may only be sold in compliance with applicable registration requirements.